Ladenburg Thalmann Financial Services’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7
Closed -$1K 5260
2018
Q3
$1K Hold
7
﹤0.01% 4994
2018
Q2
$19K Hold
7
﹤0.01% 3856
2018
Q1
$19K Hold
7
﹤0.01% 3856
2017
Q4
$17K Buy
7
+2
+40% +$4.42K ﹤0.01% 3889
2017
Q3
$10K Hold
5
﹤0.01% 4082
2017
Q2
$6K Hold
5
﹤0.01% 4253
2017
Q1
$8K Buy
+5
New +$9.15K ﹤0.01% 4108

Other funds holding IMUX

Ladenburg Thalmann Financial Services's IMUX Position: Q4 2018 in Review

Ladenburg Thalmann Financial Services sold out of Immunic (IMUX) in Q4 2018, closing a stake of 7 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in IMUX in Q1 2017 and held it in 7 quarters. The position peaked at $19K in Q2 2018. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 7 Immunic shares in Q4 2018, an estimated $1K.
  • Ladenburg Thalmann Financial Services first reported a position in Immunic in Q1 2017 and held it in 7 quarters.
  • Ladenburg Thalmann Financial Services's Immunic position peaked at $19K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2018, filed 14 Feb 2019.